Trial intelligence / Profile preview

Ciclesonide inhaler versus intravenous hydrocortisone for acute asthma exacerbation in the emergency room

RBR-6xwc26Phase 2Completed

Sponsor
Federal University of São Paulo
Start
Jan 2012
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, double-blind trial of ciclesonide and hydrocortisone in asthma and allergic asthma (2 arms), sponsored by Federal University of São Paulo. Started Jan 2012; status: completed.

02

Drugs

ciclesonidehydrocortisone
03

Conditions

asthmaallergic asthma

Beyond the preview

Go deeper on RBR-6xwc26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-6xwc26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call